Examples include the delivery of intravitreal αB crystallin ELP fusion to a mouse model of age-related macular degeneration [43], topical lacritin-ELP as an eyedrop for healing of mouse corneal wound model [44], intravitreal injection of poly(VPAVG) particles to a normal rabbit model [45], and cell-penetrating peptide ELP fusions to a normal rabbit model [46]. Here, LACRT is linked to age-related macular degeneration.